Brief: Wuyi International Pharmaceutical says HY revenue RMB 38 mln
30/08/2017 23:25
Aug 31 (Reuters) - Wuyi International Pharmaceutical Co Ltd
1889.HK
* Hy revenue rmb 38.0 million versus rmb 171.5 million
* Hy loss for period attributable rmb 493.497 million versus
loss of rmb 159.104 million
Source text for Eikon: ID:nHKS7kcPYh
Further company coverage: 1889.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Sanai Health Industry
See all newsBrief: Sanai Health Industry Says She Hao Resigned As Executive Director And Deputy CEO
Brief: Sanai Health Industry Gets Final Judgement Regarding Second Appeal From High People's Court Of Beijing
Brief: Sanai Health Industry Group Co Expects Loss Of RMB25.5 Million-RMB27.5 Million For Year
Brief: Sanai Health Industry's Unit To Sell 99% Equity Interest In Luannan Hangyang Health Industry
Brief: Sanai Health Industry Expects HY Loss Attributable Of RMB11.5 Million And RMB14.0 Million